These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34294629)

  • 41. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Electroconvulsive therapy: 80 years of use in psychiatry].
    Kaliora SC; Zervas IM; Papadimitriou GN
    Psychiatriki; 2018; 29(4):291-302. PubMed ID: 30814039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapies for depression in Parkinson's disease.
    Shabnam GN; Th C; Kho D; H R; Ce C
    Cochrane Database Syst Rev; 2003; (3):CD003465. PubMed ID: 12917968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
    Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T
    Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electroconvulsive treatment of a patient with Parkinson's disease and moderate depression.
    Berg JE
    Ment Illn; 2011 Feb; 3(1):e3. PubMed ID: 25478095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Perstimulus asystole during electroconvulsive therapy: Clinical case and critical literature review].
    Roche NC; Raynaud L; Bompaire F; Lucas JJ; Auxéméry Y
    Encephale; 2016 Feb; 42(1):59-66. PubMed ID: 26350554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment.
    Fu R; Luo XG; Ren Y; He ZY; Lv H
    Transl Neurodegener; 2016; 5():9. PubMed ID: 27175281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.
    Rask O; Suneson K; Holmström E; Bäckström B; Johansson BA
    J Med Case Rep; 2017 Dec; 11(1):345. PubMed ID: 29228982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroleptic malignant syndrome.
    Kornhuber J; Weller M
    Curr Opin Neurol; 1994 Aug; 7(4):353-7. PubMed ID: 7952245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
    Durand C; Mary S; Brazo P; Dollfus S
    Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malignant syndrome in Parkinson's disease without dopaminergic drug withdrawal.
    Chandran CJ
    Ann Indian Acad Neurol; 2008 Oct; 11(4):248-50. PubMed ID: 19893683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian cohorts.
    Cubo E; Doumbe J; Martinez-Martin P; Rodriguez-Blazquez C; Kuate C; Mariscal N; Lopez I; Noubissi G; Mapoure YN; Jon JL; Mbahe S; Tchaleu B; Catalan MJ;
    J Neurol Sci; 2014 Jan; 336(1-2):122-6. PubMed ID: 24183853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
    Fiore S; Persichino L; Anticoli S; De Pandis MF
    Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depression in Parkinson's disease: clinical-epidemiological correlates and comparison with a controlled group of non-parkinsonian geriatric patients.
    Veiga BA; Borges V; Silva SM; Goulart Fde O; Cendoroglo MS; Ferraz HB
    Braz J Psychiatry; 2009 Mar; 31(1):39-42. PubMed ID: 19506774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
    Yamawaki Y; Ogawa N
    Intern Med; 1992 Nov; 31(11):1298-302. PubMed ID: 1295627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute psychosis followed by fever--malignant neuroleptic syndrome or viral encephalitis?
    Stojanović Z; Spirić Z
    Vojnosanit Pregl; 2014 Jun; 71(6):603-7. PubMed ID: 25039118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.
    Piggott MA; Perry EK; Marshall EF; McKeith IG; Johnson M; Melrose HL; Court JA; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry RH
    Biol Psychiatry; 1998 Oct; 44(8):765-74. PubMed ID: 9798081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman.
    Gallelli L; Spagnuolo V; Palleria C; De Sarro G; Ferraro M
    Curr Drug Saf; 2009 May; 4(2):119-20. PubMed ID: 19442104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.